New diabetes tech is coming. But will it make much difference?
(By Rebecca Robbins for STAT) Pharma and tech giants are pouring hundreds of millions into diabetes technology, designing gadgets and
Read More(By Rebecca Robbins for STAT) Pharma and tech giants are pouring hundreds of millions into diabetes technology, designing gadgets and
Read More(By Rhitu Chatterjee for NPR) Diet and nutrition are now the biggest risk factors for people’s health across the globe,
Read More(By Ed Silverman for STAT) At a time when drug makers are under intense scrutiny for their pricing, Ariad Pharmaceuticals
Read More(By Meghana Keshavan for STAT) The race to create the next potent ovarian cancer drug is coming to a head. Ovarian
Read More(By Sharon Begley for STAT) Cancer research may be sucking up all the headlines lately, what with the White House
Read More(By Katherine Hobson for NPR) Mammography can prevent deaths from breast cancer, but it’s not a perfect test. Continue reading
Read More(By Associated Press for STAT) Going to the right hospital for heart attack care could add a year to your
Read More(By Joyce Cohen for STAT) Seven years ago, New York lawyer Emma Greenwood awoke to the beat of a pulse
Read More(By Ed Silverman for STAT) State prison systems are unable to lock up savings by using new hepatitis C treatments
Read More(By Karen DaSilva for STAT) Health care, like many industries, places great emphasis on innovation. In just the past decade,
Read More